EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric Glycopeptide Use in Neutropenic Fever. Mediterr J Hematol Infect Dis 2022, 14 (1), e2022039. https://doi.org/10.4084/MJHID.2022.039.